A detailed history of Janus Henderson Group PLC transactions in Axonics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 179,320 shares of AXNX stock, worth $12.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
179,320
Previous 188,028 4.63%
Holding current value
$12.7 Million
Previous $12.6 Million 1.17%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$67.3 - $69.67 $586,048 - $606,686
-8,708 Reduced 4.63%
179,320 $12.5 Million
Q2 2024

Aug 14, 2024

BUY
$66.47 - $69.65 $645,157 - $676,022
9,706 Added 5.44%
188,028 $12.6 Million
Q1 2024

May 15, 2024

BUY
$56.67 - $69.36 $8.74 Million - $10.7 Million
154,149 Added 637.69%
178,322 $12.3 Million
Q4 2023

Feb 14, 2024

SELL
$49.38 - $63.75 $1,876 - $2,422
-38 Reduced 0.16%
24,173 $1.5 Million
Q3 2023

Nov 14, 2023

BUY
$48.64 - $62.51 $145 - $187
3 Added 0.01%
24,211 $1.36 Million
Q2 2023

Aug 14, 2023

BUY
$47.99 - $60.21 $301,233 - $377,938
6,277 Added 35.01%
24,208 $1.22 Million
Q1 2023

May 15, 2023

BUY
$52.6 - $67.34 $495,649 - $634,544
9,423 Added 110.75%
17,931 $978,000
Q4 2022

Feb 14, 2023

BUY
$59.56 - $76.6 $506,736 - $651,712
8,508 New
8,508 $532,000
Q3 2022

Nov 14, 2022

SELL
$57.96 - $78.12 $76,797 - $103,509
-1,325 Reduced 16.92%
6,508 $458,000
Q2 2022

Aug 15, 2022

BUY
$39.5 - $64.42 $67,663 - $110,351
1,713 Added 27.99%
7,833 $445,000
Q1 2022

May 16, 2022

BUY
$43.74 - $62.76 $87 - $125
2 Added 0.03%
6,120 $383,000
Q4 2021

Feb 14, 2022

BUY
$50.01 - $73.35 $305,961 - $448,755
6,118 New
6,118 $342,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.